Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Octyl triazone

This article was originally published in The Tan Sheet

Executive Summary

BASF asks for 90-day extension to respond to FDA's request for data on octyl triazone sunscreen; the previous deadline was Oct. 9. Firm maintains more time is needed to compile recent effectiveness data. Beiersdorf submitted a separate letter Oct. 7 in support of BASF's time and extent application, noting the German firm has used the ingredient in its own sun care products outside the U.S. for more than five years without "unusual adverse event experience." FDA requested safety data on octyl triazone and two other sunscreen ingredients in a July 11 Federal Register notice (1"The Tan Sheet" July 14, 2003, In Brief)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096066

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel